Evidence map›Paper›PMID 29728649›Full record

ArticleNeuropsychopharmacology : official publication of the American College of Neuropsychopharmacology2018

Small molecule modulators of σ2R/Tmem97 reduce alcohol withdrawal-induced behaviors.

Luisa L Scott, James J Sahn, Antonio Ferragud, Rachel C Yen, Praveen N Satarasinghe, Michael D Wood, Timothy R Hodges, Ted Shi, Brooke A Prakash, Kaitlyn M Friese and 4 more

Open access · bronzeAbstract read
In one paragraph

Article in Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
1.9field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 41 citations in OpenAlex.

  1. Advances in drug addiction research usingFrontiers in cell and developmental biology · 2026
    Review
  2. Review
  3. Article
  4. Article
  5. Review
  6. Highly specific σProceedings of the National Academy of Sciences of the United States of America · 2023
    Article
  7. Highly specific σbioRxiv : the preprint server for biology · 2023
    Article
  8. Article
  9. σScientific reports · 2022
    Article
  10. Neuroprotective Effects of σACS chemical neuroscience · 2022
    Article
  11. Screening of σJournal of medicinal chemistry · 2022
    Article
  12. Structures of the σNature · 2021
    Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 2 institutions in 1 country.

Luisa L ScottWaggoner Center for Alcohol and Addiction Research, University of Texas at Austin, Austin, TX, 78712, USA.
James J SahnDepartment of Chemistry, University of Texas at Austin, Austin, TX, 78712, USA.
Antonio FerragudLaboratory of Addictive Disorders, Departments of Pharmacology and Experimental Therapeutics and Psychiatry, Boston University School of Medicine, Boston, USA.
Rachel C YenDepartment of Neuroscience, University of Texas at Austin, Austin, TX, 78712, USA.
Praveen N SatarasingheDepartment of Neuroscience, University of Texas at Austin, Austin, TX, 78712, USA.
Michael D WoodDepartment of Chemistry, University of Texas at Austin, Austin, TX, 78712, USA.
Timothy R HodgesDepartment of Chemistry, University of Texas at Austin, Austin, TX, 78712, USA.
Ted ShiDepartment of Neuroscience, University of Texas at Austin, Austin, TX, 78712, USA.ORCID http://orcid.org/0000-0002-8055-0955
Brooke A PrakashDepartment of Neuroscience, University of Texas at Austin, Austin, TX, 78712, USA.
Kaitlyn M FrieseDepartment of Neuroscience, University of Texas at Austin, Austin, TX, 78712, USA.
Angela ShenDepartment of Neuroscience, University of Texas at Austin, Austin, TX, 78712, USA.
Valentina SabinoLaboratory of Addictive Disorders, Departments of Pharmacology and Experimental Therapeutics and Psychiatry, Boston University School of Medicine, Boston, USA.
Jonathan T PierceWaggoner Center for Alcohol and Addiction Research, University of Texas at Austin, Austin, TX, 78712, USA.
Stephen F MartinWaggoner Center for Alcohol and Addiction Research, University of Texas at Austin, Austin, TX, 78712, USA. sfmartin@mail.utexas.edu.
The University of Texas at Austin · USBoston University · US

Funding

A screen for peptides that alter BK channel-mediated alcohol intoxicationR01AA020992 · NIAAA · UNIVERSITY OF TEXAS AT AUSTIN · PI ALDRICH, RICHARD, MIHIC, S JOHN · 2012 to 2016
$2.0M
Synergistic patterned neurodegeneration by APP and APOE4RF1AG057355 · NIA · UNIVERSITY OF TEXAS AT AUSTIN · PI PIERCE, JONATHAN THOMAS · 2017 to 2017
$1.9M
Prefrontal cortex in excessive alcohol drinking: role of sigma receptorsR01AA024439 · NIAAA · BOSTON UNIVERSITY MEDICAL CAMPUS · PI SABINO, VALENTINA · 2016 to 2020
$1.8M
NIAAA NIH HHS R01 AA020992NIAAA NIH HHS R01 AA024439NIA NIH HHS RF1 AG057355
6 · The paper itself

Abstract

Repeated cycles of intoxication and withdrawal enhance the negative reinforcing properties of alcohol and lead to neuroadaptations that underlie withdrawal symptoms driving alcohol dependence. Pharmacotherapies that target these neuroadaptations may help break the cycle of dependence. The sigma-1 receptor (σ1R) subtype has attracted interest as a possible modulator of the rewarding and reinforcing effects of alcohol. However, whether the sigma-2 receptor, recently cloned and identified as transmembrane protein 97 (σ2R/TMEM97), plays a role in alcohol-related behaviors is currently unknown. Using a Caenorhabditis elegans model, we identified two novel, selective σ2R/Tmem97 modulators that reduce alcohol withdrawal behavior via an ortholog of σ2R/TMEM97. We then show that one of these compounds blunted withdrawal-induced excessive alcohol drinking in a well-established rodent model of alcohol dependence. These discoveries provide the first evidence that σ2R/TMEM97 is involved in alcohol withdrawal behaviors and that this receptor is a potential new target for treating alcohol use disorder.

Indexed as

Alcohol-Related DisordersAnimalsCaenorhabditis elegansCentral Nervous System AgentsCentral Nervous System DepressantsDose-Response Relationship, DrugDrug DiscoveryEthanolRatsReceptors, sigmaSubstance Withdrawal SyndromeCentral Nervous System AgentsCentral Nervous System DepressantsEthanolReceptors, sigmasigma-2 receptor

Identifiers

PMID29728649
PMCPMC6046036
OpenAlexW2800940990

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.